CSF Biomarkers Characterized in Patients With Fragile X-Associated Tremor/Ataxia Syndrome
Researchers shared their findings on the cerebrospinal fluid profile of patients with fragile X-associated tremor/ataxia syndrome and potential biomarkers.
All articles by Amit Akirov, MD
Safety and Efficacy of Venglustat Assessed in GBA Gene Carriers With Parkinson Disease
In a poster presented at MDS 2021 and as part 2 of the MOVES-PD trial, researchers assessed the safety and efficacy of venglustat, a glucosylceramide synthase inhibitor, in patients stratified by GBA gene variation severity.
Specialized Light Therapy Improves Motor and Nonmotor Symptoms in Parkinson Disease
Researchers assessed the impact of specialized light therapy on motor and nonmotor symptoms in patients with Parkinson disease.
Ecopipam Shows Promise in Tic Reduction in Children With Tourette Syndrome
In a study presented at MDS 2021, researchers assessed the long-term safety and activity of ecopipam, a selective D1 antagonist, in reducing tics in children with Tourette syndrome.
What Is the Effect of Parkinson Disease Medications on the Gut Microbiome?
Researchers observed the differences in gut microbiota composition between drug-naive and medically treated patients with Parkinson disease.
Assessing the Link Between Alzheimer Disease Co-Pathology and Neuropsychiatric Symptoms in Lewy Body Dementia
Researchers explored the association between Alzheimer disease co-pathology and the presence and severity of neuropsychiatric symptoms in Lewy body dementia.
Is Restless Legs Syndrome Tied to Depression and Cognitive Dysfunction?
At MDS 2021, researchers shared study results on the prevalence of cognitive dysfunction and depression in patients with restless legs syndrome (RLS) and the impact of RLS severity on these variables.
Early Levodopa Exposure Associated With Earlier Onset of Motor Fluctuations in Parkinson Disease
In a poster presented at MDS 2021, researchers reported on the effect of early levodopa exposure on the onset of motor complications in patients with Parkinson disease.
Migraine Management: How to Treat Patients With Vascular Disease
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
Does Anakinra Have a Role in the Treatment of Severe COVID-19?
Authors of a commentary assessed the role of IL-1 receptor antagonism, specifically anakinra, in the treatment of patients with severe COVID-19.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...